Related Experiment Video

Updated: Apr 19, 2026

A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy
09:56

A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy

Published on: February 21, 2025

1.6K

Current advances in T-cell-based cancer immunotherapy

Mingjun Wang1, Bingnan Yin, Helen Y Wang

  • 1Center for Inflammation & Epigenetics, Houston Methodist Research Institute, Houston, TX 77030, USA.

Immunotherapy
|December 20, 2014
PubMed

Insights

Cancer immunotherapy, specifically adoptive cell transfer, offers new hope for late-stage cancer patients. This approach shows promise for treating refractory cancers where traditional methods fail, highlighting its potential in cancer treatment.

Area of Science:

  • Oncology
  • Immunology
  • Biomedical Research

Background:

  • Cancer remains a leading global cause of mortality.
  • Late-stage diagnosis, due to a lack of early detection biomarkers, limits treatment success.
  • Conventional therapies (surgery, chemotherapy, radiation) show limited efficacy in advanced or refractory cancers.

Purpose of the Study:

  • To review recent advancements in adoptive cell transfer (ACT) based cancer immunotherapy.
  • To discuss future directions and potential of ACT for treating late-stage and refractory cancers.

Main Methods:

  • Literature review of current research in cancer immunotherapy.
  • Focus on adoptive cell transfer techniques and their clinical applications.

Main Results:

  • Adoptive cell transfer demonstrates significant promise for treating late-stage cancers.
  • ACT offers a viable therapeutic option for patients refractory to standard treatments.

Conclusions:

  • Cancer immunotherapy, particularly ACT, represents a promising frontier in oncology.
  • Further research and development in ACT are crucial for improving outcomes in advanced cancer patients.
Keywords:
adoptive cell transfercancer antigen-specific T cellscancer immunotherapygenetically modified T cells

More Related Videos

Generation of CAR T Cells for Adoptive Therapy in the Context of Glioblastoma Standard of Care12:55

Generation of CAR T Cells for Adoptive Therapy in the Context of Glioblastoma Standard of Care

Published on: February 16, 2015

22.2K
Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine09:15

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine

Published on: February 24, 2023

4.2K

Related Concept Videos

Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.6K
Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
1.4K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
9.2K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

1.8K
Cytotoxic T Cells-mediated Immune Response01:27

Cytotoxic T Cells-mediated Immune Response

Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
8.5K
T Cell Activation and Clonal Selection01:22

T Cell Activation and Clonal Selection

T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
17.9K